XML 33 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurements (Tables)
9 Months Ended
Feb. 29, 2016
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company’s financial assets measured at fair value on a recurring basis as of February 29, 2016 and May 31, 2015, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of February 29, 2016
(In millions)
 
Assets at Fair Value
 
Cash and Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
809

 
$
809

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
1,027

 

 
1,027

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
695

 
695

 

 

U.S. Agency securities
 
593

 
50

 
543

 

Commercial paper and bonds
 
697

 
205

 
492

 

Money market funds
 
1,285

 
1,285

 

 

Total Level 2:
 
3,270

 
2,235

 
1,035

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
20

 

 

 
20

TOTAL
 
$
5,126

 
$
3,044

 
$
2,062

 
$
20


 
 
As of May 31, 2015
(In millions)
 
Assets at Fair Value
 
Cash and Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
615

 
$
615

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
869

 
225

 
644

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
684

 
684

 

 

U.S. Agency securities
 
976

 
110

 
866

 

Commercial paper and bonds
 
914

 
352

 
562

 

Money market funds
 
1,866

 
1,866

 

 

Total Level 2:
 
4,440

 
3,012

 
1,428

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
8

 

 

 
8

TOTAL
 
$
5,932

 
$
3,852

 
$
2,072

 
$
8

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following tables present information about the Company’s derivative assets and liabilities measured at fair value on a recurring basis as of February 29, 2016 and May 31, 2015, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of February 29, 2016
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
963

 
$
720

 
$
243

 
$
117

 
$
103

 
$
14

Embedded derivatives
 
5

 
1

 
4

 
11

 
3

 
8

Interest rate swaps(2)
 

 

 

 
54

 
54

 

TOTAL
 
$
968

 
$
721

 
$
247

 
$
182

 
$
160

 
$
22

(1)
If the foreign exchange derivative instruments had been netted on the Unaudited Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $116 million as of February 29, 2016. As of that date, the Company had received $338 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of February 29, 2016.
(2)
As of February 29, 2016, no amount of cash collateral had been posted on the derivative liability balance related to the Company's interest rate swaps.
 
 
As of May 31, 2015
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
1,554

 
$
1,034

 
$
520

 
$
164

 
$
160

 
$
4

Embedded derivatives
 
7

 
2

 
5

 
11

 
2

 
9

Interest rate swaps(2)
 
78

 
78

 

 

 

 

TOTAL
 
$
1,639

 
$
1,114

 
$
525

 
$
175

 
$
162

 
$
13

(1)
If the foreign exchange derivative instruments had been netted on the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $161 million as of May 31, 2015. As of that date, the Company had received $900 million of cash collateral and $74 million of securities from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of May 31, 2015.
(2)
As of May 31, 2015, the Company had received $68 million of cash collateral related to its interest rate swaps.
The following table presents the fair values of derivative instruments included within the Unaudited Condensed Consolidated Balance Sheets as of February 29, 2016 and May 31, 2015: 
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Balance Sheet
Location
 
February 29,
2016
 
May 31,
2015
 
Balance Sheet 
Location
 
February 29,
2016
 
May 31,
2015
Derivatives formally designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
$
657

 
$
825

 
Accrued liabilities
 
$
26

 
$
140

Interest rate swaps
 
Prepaid expenses and other current assets
 

 
78

 
Accrued liabilities
 
54

 

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
227

 
520

 
Deferred income taxes and other liabilities
 
14

 
4

Total derivatives formally designated as hedging instruments
 
 
 
884

 
1,423

 
 
 
94

 
144

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
63

 
209

 
Accrued liabilities
 
77

 
20

Embedded derivatives
 
Prepaid expenses and other current assets
 
1

 
2

 
Accrued liabilities
 
3

 
2

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
16

 

 
Deferred income taxes and other liabilities
 

 

Embedded derivatives
 
Deferred income taxes and other assets
 
4

 
5

 
Deferred income taxes and other liabilities
 
8

 
9

Total derivatives not designated as hedging instruments
 
 
 
84

 
216

 
 
 
88

 
31

TOTAL DERIVATIVES
 
 
 
$
968

 
$
1,639

 
 
 
$
182

 
$
175